Textbook of Benign Prostatic Hyperplasia
The first edition of this break-through title was enthusiastically received by urologists around the world and became the standard reference work on the subject of BPH. However, with constant changes and improvements being made in therapeutics and treatment in general, any book on this important subject will need frequent updating.
Now the first edition's original sections have been expanded and, once again, a team of expert editors and contributors ensure that readers are presented with the latest information about BPH on everything from pathophysiology through to the latest treatments and clinical trials including MTOPS and PREDICT.
| Author: |
Roger S. Kirby, John M. Fitzpatrick, John D. McConnell, Claus G. Roehrborn, Peter Boyle |
| Edition: |
2 |
| ISBN: |
190186555X |
| Binding: |
Hardcover |
| Year Published: |
Oct. 2004 |
| No. of Pages: |
576 |
| Illustrations: |
125 |
| Contents: |
| 1. Macro-anatomy of the Prostate. 2. Embryology and Development of the Prostate. 3. Molecular Control of Prostate Growth. 4. Stormal-epithelial Interactions: Molecular Aspects and Relevance to Benign Prostatic Hyperplasia. 5. Human Prostatic Adrenoceptors. 6. The Pathology of Benign Prostatic Hyperplasia. 7. Bladder Responses to Obstruction. 8. Molecular Genetics of Benign Prostatic Hyperplasia. 9. Measuring and Assessing Benign Prostatic Hyperplasia in Population Groups. 10. Descriptive Epidemiology of Benign Prostatic Hyperplasia. 11. Aetiology of Benign Prostatic Hyperplasia. 12. Epidemiology of Acute Urinary Retention. 13. Natural History of Benign Prostatic Hyperplasia. 14. Evaluating Symptoms and Functional Status and Sexual Function. 15. Benign Prostatic Hyperplasia Prostate Volume Assessment. 16. Diagnosis of Prostate Cancer in Men with Benign Prostatic Hyperplasia. 17. Flow Rate and Post-void Residual (PVR) Issues. 18. Urodynamics and Benign Prostatic Hyperplasia. 19. Imaging and Benign Prostatic Hyperplasia. 20. The Role and Interpretation of Core Biopsies in Clinical Practice. 21. Neurological and Neurophysiological Assessment. 22. Watchful Waiting. 23. The Placebo Effect in the Treatment of Benign Prostatic Hyperplasia. 24. Dual 5-alpha Reductase Inhibition as a Therapeutic Target: the Development of GI198745. 25. 5-alpha-reductase Therapy in Benign Prostatic Hyperplasia. 26. Combination Therapies Including MTOPS 27. Tissue Proliferation: Differential Effects of Adrenoceptor Antagonists. 28. Terazosin in the Treatment of Obstruction of the Lower Urinary Tract. 29. Doxazosin in the Treatment of Benign Prostatic Hyperplasia. 30. Alfuzosin. 31. Tamsulosin. 32. Combination Therapies for Benign Prostatic Hyperplasia. 33. Phytotherapeutic Agents in the Treatment of LUTS and Benign Prostatic Hyperplasia. 34. Uroselectivity. 35. Standard Surgical Interventional: TUIP/TURP/OPSU. 36. Transurethral Laser Prostatectomy. 37. Interstitial Laser Therapy for Benign Prostatic Hyperplasia. 38. Transurethral Needle Ablation of the Prostate (TUNA) for Treatment of Benign Prostatic Hyperplasia. 39. Temporary Stents. 40. Guidelines for Diagnosis and Management of Benign Prostatic Hyperplasia. 41. Treatment Outcomes and Their Interpretation in Benign Prostatic Hyperplasia. 42. Shared Care for Benign Prostatic Hyperplasia. 43. The Impact of Benign Prostatic Hyperplasia on Sexual Function |
|
|
|
Please note
Publishers prices can change unexpectedly. If the price of your book has changed we will contact you.
|
